A role for systems epidemiology in tuberculosis research

Trends in Microbiology

Volumn 19, Issue 10, 2011, Pages 492-500

  Comas, Iñaki ^a   Gagneux, Sebastien ^b,c  

^a NATIONAL INSTITUTE FOR MEDICAL RESEARCH   (United Kingdom)

^b SWISS TROPICAL AND PUBLIC HEALTH INSTITUTE   (Switzerland)

^c UNIVERSITY OF BASEL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE; ETHAMBUTOL; TUBERCULOSTATIC AGENT;

BACTERIAL GENE; BACTERIAL GENETICS; BACTERIAL STRAIN; BACTERIAL VIRULENCE; CELLULAR IMMUNITY; DEMOGRAPHY; DISEASE COURSE; ENVIRONMENTAL FACTOR; EXTRAPULMONARY TUBERCULOSIS; GENE SEQUENCE; HOST PATHOGEN INTERACTION; HUMAN; INCIDENCE; INNATE IMMUNITY; LUNG GRANULOMA; LUNG TUBERCULOSIS; MOLECULAR EPIDEMIOLOGY; MOLECULAR EVOLUTION; MOLECULAR GENETICS; MULTIDRUG RESISTANT TUBERCULOSIS; MYCOBACTERIUM BOVIS; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PATIENT COMPLIANCE; PHYLOGENY; PRIORITY JOURNAL; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; SOCIOECONOMICS; SPUTUM CYTODIAGNOSIS; TUBERCULOSIS; TUBERCULOSIS CONTROL;

BIOMEDICAL RESEARCH; ENVIRONMENT; EVOLUTION, MOLECULAR; HOST-PATHOGEN INTERACTIONS; HUMANS; MYCOBACTERIUM TUBERCULOSIS; SOCIOECONOMIC FACTORS; TUBERCULOSIS;

MYCOBACTERIUM TUBERCULOSIS;

EID: 80053265890     PISSN: 0966842X     EISSN: 18784380     Source Type: Journal    
DOI: 10.1016/j.tim.2011.07.002     Document Type: Review

References (80)

1. Smith N.H., et al. Ecotypes of the Mycobacterium tuberculosis complex. J. Theor. Biol. 2006, 239:220-225.
2. World Health Organization Global Tuberculosis Control: Surveillance, Planning, Financing 2010, WHO.
3. Dye C., Williams B.G. The population dynamics and control of tuberculosis. Science 2010, 328:856-861.
4. Young D., et al. Systems biology of persistent infection: tuberculosis as a case study. Nat. Rev. Microbiol. 2008, 6:520-528.
5. Young D.B., et al. Confronting the scientific obstacles to global control of tuberculosis. J. Clin. Invest. 2008, 118:1255-1265.
6. Boehme C.C., et al. Rapid molecular detection of tuberculosis and rifampin resistance. N. Engl. J. Med. 2010, 363:1005-1015.
7. Barry C.E., et al. The spectrum of latent tuberculosis: rethinking the biology and intervention strategies. Nat. Rev. Microbiol. 2009, 7:845-855.
8. Pai M. Spectrum of latent tuberculosis: existing tests cannot resolve the underlying phenotypes. Nat. Rev. Microbiol. 2010, 8:242.
9. Berry M.P., et al. An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosis. Nature 2010, 466:973-977.
10. Zur Wiesch P.A., et al. Population biological principles of drug-resistance evolution in infectious diseases. Lancet Infect. Dis. 2011, 11:236-247.
11. Pyle M.M. Relative numbers of resistant tubercle bacilli in sputa of patients before and during treatment with streptomycin. Mayo Clin. Proc. 1947, 22:465-473.
12. Gandhi N.R., et al. Multidrug-resistant and extensively drug-resistant tuberculosis: a threat to global control of tuberculosis. Lancet 2010, 375:1830-1843.
13. Brudney K., Dobkin J. Resurgent tuberculosis in New York City. Human immunodeficiency virus, homelessness, and the decline of tuberculosis control programs. Am. Rev. Respir. Dis. 1991, 144:745-749.
14. Kaufmann S.H., Parida S.K. Changing funding patterns in tuberculosis. Nat. Med. 2007, 13:299-303.
15. Andersen P., Doherty T.M. Opinion: the success and failure of BCG: implications for a novel tuberculosis vaccine. Nat. Rev. Microbiol. 2005, 3:656-662.
16. Colditz G.A., et al. Efficacy of BCG vaccine in the prevention of tuberculosis. Meta-analysis of the published literature. JAMA 1994, 271:698-702.
17. Kaufmann S.H., et al. New vaccines for tuberculosis. Lancet 2010, 375:2110-2119.
18. Russell D.G., et al. Tuberculosis: what we don't know can, and does, hurt us. Science 2010, 328:852-856.
19. Aderem A., et al. A systems biology approach to infectious disease research: innovating the pathogen-host research paradigm. MBio 2011, 2. e00325-e00310.
20. Kitano H. Systems biology: a brief overview. Science 2002, 295:1662-1664.
21. Mardis E.R. Next-generation DNA sequencing methods. Annu. Rev. Genomics Hum. Genet. 2008, 9:387-402.
22. Kunnath-Velayudhan S., et al. Dynamic antibody responses to the Mycobacterium tuberculosis proteome. Proc. Natl. Acad. Sci. U.S.A. 2010, 107:14703-14708.
23. de Carvalho L.P., et al. Metabolomics of Mycobacterium tuberculosis reveals compartmentalized co-catabolism of carbon substrates. Chem. Biol. 2010, 17:1122-1131.
24. Zhang W., et al. Integrating multiple 'omics' analysis for microbial biology: application and methodologies. Microbiology 2010, 156:287-301.
25. Ray J.C., et al. Synergy between individual TNF-dependent functions determines granuloma performance for controlling Mycobacterium tuberculosis infection. J. Immunol. 2009, 182:3706-3717.
26. Comas I., Gagneux S. The past and future of tuberculosis research. PLoS Pathog. 2009, 5:e1000600.
27. The Modern Rise of Population 1976, Academic Press. T. McKeown (Ed.).
28. Lonnroth K., et al. Drivers of tuberculosis epidemics: the role of risk factors and social determinants. Soc. Sci. Med. 2009, 68:2240-2246.
29. Gagneux S., Small P.M. Global phylogeography of Mycobacterium tuberculosis and implications for tuberculosis product development. Lancet Infect. Dis. 2007, 7:328-337.
30. Tishkoff S.A., et al. The genetic structure and history of Africans and African Americans. Science 2009, 324:1035-1044.
31. Moller M., et al. Past, present and future directions in human genetic susceptibility to tuberculosis. FEMS Immunol. Med. Microbiol. 2010, 58:3-26.
32. Coscolla M., Gagneux S. Does M. tuberculosis genomic diversity explain disease diversity?. Drug Discov. Today Dis. Mech. 2010, 7:e43-e59.
33. Caws M., et al. The influence of host and bacterial genotype on the development of disseminated disease with Mycobacterium tuberculosis. PLoS Pathog. 2008, 4:e1000034.
34. Thye T., et al. Variant G57E of mannose binding lectin associated with protection against tuberculosis caused by Mycobacterium africanum but not by M. tuberculosis. PLoS ONE 2011, 6:e20908.
35. Intemann C.D., et al. Autophagy gene variant IRGM -261T contributes to protection from tuberculosis caused by Mycobacterium tuberculosis but not by M. africanum strains. PLoS Pathog. 2009, 5:e1000577.
36. Herb F., et al. ALOX5 variants associated with susceptibility to human pulmonary tuberculosis. Hum. Mol. Genet. 2008, 17:1052-1060.
37. van Crevel R., et al. Infection with Mycobacterium tuberculosis Beijing genotype strains is associated with polymorphisms in SLC11A1/NRAMP1 in Indonesian patients with tuberculosis. J. Infect. Dis. 2009, 200:1671-1674.
38. Achtman M. A surfeit of YATMs?. J. Clin. Microbiol. 1996, 34:1870.
39. Kato-Maeda M., et al. Genotyping of Mycobacterium tuberculosis: application in epidemiologic studies. Future Microbiol. 2011, 6:203-216.
40. Comas I., et al. Genotyping of genetically monomorphic bacteria: DNA sequencing in Mycobacterium tuberculosis highlights the limitations of current methodologies. PLoS ONE 2009, 4:e7815.
41. Achtman M. Evolution, population structure, and phylogeography of genetically monomorphic bacterial pathogens. Annu. Rev. Microbiol. 2008, 62:53-70.
42. Gagneux S., et al. Variable host-pathogen compatibility in Mycobacterium tuberculosis. Proc. Natl. Acad. Sci. U.S.A. 2006, 103:2869-2873.
43. Hirsh A.E., et al. Stable association between strains of Mycobacterium tuberculosis and their human host populations. Proc. Natl. Acad. Sci. U.S.A. 2004, 101:4871-4876.
44. Brosch R., et al. A new evolutionary scenario for the Mycobacterium tuberculosis complex. Proc. Natl. Acad. Sci. U.S.A. 2002, 99:3684-3689.
45. Mostowy S., et al. Genomic deletions suggest a phylogeny for the Mycobacterium tuberculosis complex. J. Infect. Dis. 2002, 186:74-80.
46. Baker L., et al. Silent nucleotide polymorphisms and a phylogeny for Mycobacterium tuberculosis. Emerg. Infect. Dis. 2004, 10:1568-1577.
47. Gutacker M.M., et al. Single-nucleotide polymorphism-based population genetic analysis of Mycobacterium tuberculosis strains from 4 geographic sites. J. Infect. Dis. 2006, 193:121-128.
48. Filliol I., et al. Global phylogeny of Mycobacterium tuberculosis based on single nucleotide polymorphism (SNP) analysis: insights into tuberculosis evolution, phylogenetic accuracy of other DNA fingerprinting systems, and recommendations for a minimal standard SNP set. J. Bacteriol. 2006, 188:759-772.
49. Dos Vultos T., et al. Evolution and diversity of clonal bacteria: the paradigm of Mycobacterium tuberculosis. PLoS ONE 2008, 3:e1538.
50. Hershberg R., et al. High functional diversity in Mycobacterium tuberculosis driven by genetic drift and human demography. PLoS Biol. 2008, 6:e311.
51. Comas I., et al. Human T cell epitopes of Mycobacterium tuberculosis are evolutionarily hyperconserved. Nat. Genet. 2010, 42:498-503.
52. Tsolaki A.G., et al. Functional and evolutionary genomics of Mycobacterium tuberculosis: insights from genomic deletions in 100 strains. Proc. Natl. Acad. Sci. U.S.A. 2004, 101:4865-4870.
53. de Jong B.C., et al. Mycobacterium africanum: review of an important cause of human tuberculosis in West Africa. PLoS Negl. Trop. Dis. 2010, 4:e744.
54. Wirth T., et al. Origin, spread and demography of the Mycobacterium tuberculosis complex. PLoS Pathog. 2008, 4:e1000160.
55. May R.M., Anderson R.M. Epidemiology and genetics in the coevolution of parasites and hosts. Proc. R. Soc. Lond. B: Biol. Sci. 1983, 219:281-313.
56. Flynn J.L., Chan J. Immunology of tuberculosis. Annu. Rev. Immunol. 2001, 19:93-129.
57. Russell D.G. Mycobacterium tuberculosis and the intimate discourse of a chronic infection. Immunol. Rev. 2011, 240:252-268.
58. Nicol M.P., Wilkinson R.J. The clinical consequences of strain diversity in Mycobacterium tuberculosis. Trans. R. Soc. Trop. Med. Hyg. 2008, 102:955-965.
59. Portevin D., et al. Human macrophage responses to clinical isolates from the Mycobacterium tuberculosis complex discriminate between ancient and modern lineages. PLoS Pathog. 2011, 7:e1001307.
60. Reed M.B., et al. A glycolipid of hypervirulent tuberculosis strains that inhibits the innate immune response. Nature 2004, 431:84-87.
61. Manca C., et al. Virulence of a Mycobacterium tuberculosis clinical isolate in mice is determined by failure to induce Th1 type immunity and is associated with induction of IFN-alpha/beta. Proc. Natl. Acad. Sci. U.S.A. 2001, 98:5752-5757.
62. de Jong B.C., et al. Progression to active tuberculosis, but not transmission, varies by Mycobacterium tuberculosis lineage in The Gambia. J. Infect. Dis. 2008, 198:1037-1043.
63. Palmer G.H., et al. 'Nothing is permanent but change': antigenic variation in persistent bacterial pathogens. Cell Microbiol. 2009, 11:1697-1705.
64. Musser J.M., et al. Negligible genetic diversity of Mycobacterium tuberculosis host immune system protein targets: evidence of limited selective pressure. Genetics 2000, 155:7-16.
65. Sassetti C.M., Rubin E.J. Genetic requirements for mycobacterial survival during infection. Proc. Natl. Acad. Sci. U.S.A. 2003, 100:12989-12994.
66. Rodrigo T., et al. Characteristics of tuberculosis patients who generate secondary cases. Int. J. Tuberc. Lung Dis. 1997, 1:352-357.
67. Barber D.L., et al. CD4 T cells promote rather than control tuberculosis in the absence of PD-1-mediated inhibition. J. Immunol. 2011, 186:1598-1607.
68. Flynn J.L., Chan J. What's good for the host is good for the bug. Trends Microbiol. 2005, 13:98-102.
69. Eisen J.A., MacCallum C.J. Genomics of emerging infectious disease: a PLoS collection. PLoS Biol. 2009, 7:e1000224.
70. Croucher N.J., et al. Rapid pneumococcal evolution in response to clinical interventions. Science 2011, 331:430-434.
71. Lewis T., et al. High-throughput whole-genome sequencing to dissect the epidemiology of Acinetobacter baumannii isolates from a hospital outbreak. J. Hosp. Infect. 2010, 75:37-41.
72. Niemann S., et al. Genomic diversity among drug sensitive and multidrug resistant isolates of Mycobacterium tuberculosis with identical DNA fingerprints. PLoS ONE 2009, 4:e7407.
73. Schurch A.C., et al. High resolution typing by integration of genome sequencing data in a large tuberculosis cluster. J. Clin. Microbiol. 2010, 48:3403-3406.
74. Gardy J.L., et al. Whole-genome sequencing and social-network analysis of a tuberculosis outbreak. N. Engl. J. Med. 2011, 364:730-739.
75. Goldfeld A.E., et al. Association of an HLA-DQ allele with clinical tuberculosis. JAMA 1998, 279:226-228.
76. Barnes I., et al. Ancient urbanization predicts genetic resistance to tuberculosis. Evolution 2011, 65:842-848.
77. Cowley D., et al. Recent and rapid emergence of W-Beijing strains of Mycobacterium tuberculosis in Cape Town, South Africa. Clin. Infect. Dis. 2008, 47:1252-1259.
78. Zhang Q., et al. Immune epitope database analysis resource (IEDB-AR). Nucleic Acids Res. 2008, 36:W513-W518.
79. Gonzalez-Galarza F.F., et al. Allele frequency net: a database and online repository for immune gene frequencies in worldwide populations. Nucleic Acids Res. 2011, 39:D913-D919.
80. Reddy T.B., et al. TB database: an integrated platform for tuberculosis research. Nucleic Acids Res. 2009, 37:D499-D508.